Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Aadi Biosciences Inc (NQ: AADI ) 1.430 -0.100 (-6.54%) Streaming Delayed Price Updated: 4:00 PM EDT, Jul 19, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Aadi Biosciences Inc < Previous 1 2 Next > Stocks That Hit 52-Week Lows On Monday March 06, 2023 On Monday, 36 companies set new 52-week lows. Via Benzinga 5 Value Stocks In The Healthcare Sector January 30, 2023 Via Benzinga Aadi Bioscience: Q2 Earnings Insights August 10, 2022 Aadi Bioscience (NASDAQ:AADI) reported its Q2 earnings results on Wednesday, August 10, 2022 at 07:00 AM. Here's what investors need to know about the announcement. Via Benzinga Aadi Bioscience: Q1 Earnings Insights May 12, 2022 Aadi Bioscience (NASDAQ:AADI) reported its Q1 earnings results on Thursday, May 12, 2022 at 07:00 AM. Here's what investors need to know about the announcement. Earnings Aadi Bioscience beat estimated... Via Benzinga HC Wainwright & Co. Maintains Buy Rating for Aadi Bioscience, Lowers Price Target To $48 April 11, 2022 HC Wainwright & Co. has decided to maintain its Buy rating of Aadi Bioscience (NASDAQ:AADI) and lower its price target from $49.00 to $48.00. Shares of Aadi Bioscience are trading down 4.87% over the... Via Benzinga Aadi Bioscience: Q4 Earnings Insights March 17, 2022 Aadi Bioscience (NASDAQ:AADI) reported its Q4 earnings results on Thursday, March 17, 2022 at 07:00 AM. Here's what investors need to know about the announcement.... Via Benzinga Canadian Biotech Disruptor Lexston Life Sciences is unlocking the God Molecule (LEXTF, ICPT, AKBA, QURE, BNTX, SAVA) January 19, 2022 Via AB Newswire Topics Bonds Stocks Exposures Debt Markets US Equities 12 Health Care Stocks Moving In Thursday's Pre-Market Session December 02, 2021 Gainers Omeros (NASDAQ:OMER) stock increased by 15.68% to $7.89 during Thursday's pre-market session. The market value of their outstanding shares is at $493.4 million... Via Benzinga The Week Ahead In Biotech (Nov. 28-Dec. 4): FDA Decisions For VBI Vaccines, & More November 28, 2021 Biotech stocks advanced in the week ending Nov. 26, as a late-week surge on the back of news about a new COVID-19 variant helped mitigate the losses notched earlier in the holiday-shortened week. Via Talk Markets Exposures COVID-19 Product Safety The Week Ahead In Biotech (Nov. 28-Dec. 4): FDA Decisions For VBI Vaccines, BeyondSpring, CTI Biopharma And Merck Take The Spotlight In A Light Calendar Week November 28, 2021 Biotech stocks advanced in the week ending Nov. 26, as a late-week surge on the back of news about a new COVID-19 variant, named Omicron, helped mitigate the losses... Via Benzinga Exposures COVID-19 Product Safety What 4 Analyst Ratings Have To Say About Aadi Bioscience November 24, 2021 Analysts have provided the following ratings for Aadi Bioscience (NASDAQ:AADI Via Benzinga Aadi Bioscience Stock Pops On First-Ever FDA Approval In Rare Cancer November 23, 2021 Aadi Bioscience won FDA approval for a drug to treat rare tumors. Via Investor's Business Daily Exposures Product Safety The Daily Biotech Pulse: Arrowhead Out-Licenses NASH Drug, Tonix Touts COVID-19 Treatment Data, Aadi Jumps On FDA Nod For Rare Tumor Drug November 23, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Synlogic Presents Positive Phase 2 Data For Synthetic Biologic Treatment In... Via Benzinga Exposures COVID-19 Product Safety 12 Health Care Stocks Moving In Tuesday's Pre-Market Session November 23, 2021 Gainers Pasithea Therapeutics (NASDAQ:KTTA) stock increased by 157.46% to $5.69 during Tuesday's pre-market session. The company's market cap stands at $75.1... Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday November 23, 2021 Good morning, investors! We're getting right back to the grind today with a dive into the biggest pre-market stock movers for Tuesday. Via InvestorPlace Exposures COVID-19 Product Safety Aadi Bioscience Shares Rally On FDA Approval For Its First Product For Rare Form Cancer November 23, 2021 The FDA has approved Aadi Bioscience Inc's (NASDAQ: AADI) Fyarro (sirolimus protein-bound particles for injectable suspension) (albumin-bound) for perivascular... Via Benzinga Exposures Product Safety The Week Ahead In Biotech (Nov. 21-Nov. 27): FDA Decisions, Earnings In The Spotlight In Holiday-Shortened Week November 21, 2021 Biotech stocks showed a lack of direction in the week ending Nov. 19 before finishing modestly higher. Stocks did not have much meaningful catalysts to react to amid the winding down of the reporting... Via Talk Markets Exposures Product Safety The Week Ahead In Biotech (Nov. 21-Nov. 27): Takeda, Aadi, Fennec FDA Decisions, Earnings In The Spotlight In Holiday-Shortened Week November 21, 2021 Biotech stocks showed a lack of direction in the week ending Nov. 19 before finishing modestly higher. Stocks did not have much meaningful catalysts to react to amid the... Via Benzinga Exposures Product Safety 76 Biggest Movers From Yesterday November 11, 2021 Gainers Expensify, Inc. (NASDAQ: EXFY) jumped 52.1% to settle at $41.06 on Wednesday after the company priced its IPO at $27 per share. RenovoRx, Inc. (NASDAQ: RNXT) shares... Via Benzinga Topics Initial Public Offering Exposures Securities Market Attention Biotech Investors: Mark Your Calendar For November PDUFA Dates November 02, 2021 The loaded Prescription Drug User Fee Act (PDUFA) calendar for October produced mixed outcomes. PDUFA dates are key binary events for biotech stocks that can move the needle in a... Via Benzinga The Daily Biotech Pulse: Pfizer Reports Solid Q3 Earnings, Regulatory Setback For Legend, Lilly to Supply Additional COVID-19 Antibody Cocktails To US November 02, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus SAB Spikes On Analyst Action SAB Biotherapeutics, Inc. (NASDAQ: SABS) shares... Via Benzinga Exposures COVID-19 Benzinga's Top Ratings Upgrades, Downgrades For October 1, 2021 October 01, 2021 Upgrades Northland Capital Markets upgraded the previous rating for Five9 Inc (NASDAQ: Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For September 8, 2021 September 08, 2021 Upgrades For SilverBow Resources Inc (NYSE: Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For September 14, 2021 September 14, 2021 Upgrades Northcoast Research upgraded the previous rating for Casey's General Stores Inc ... Via Benzinga 60 Biggest Movers From Friday August 30, 2021 Gainers Vinco Ventures, Inc. (NASDAQ: BBIG) shares rose 80.9% to close at $5.30 on Friday. The company recently reported a Q2 loss of $5.13 per share. Navios Maritime Acquisition... Via Benzinga < Previous 1 2 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.